Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Mums Vs Big Pharma 9pm BBC tonight
Please or to access all these features Share your dilemmas and get honest opinions from other Mumsnetters. Unbelievabl · Today 15:47 I heard this on the radio this morning. From the makers of the post office scandal. It's already on iplayer…
BDR Pharma to acquire stake in Acme's oral solid formulations business
Updated - November 09, 2026 09:50 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers BDR Pharma will acquire a controlling stake in the oral solid formulations business of…
BDR Pharma buys majority stake in oral care biz of Acme Formulation
The acquisition aligns with BDR's growth priorities across oncology, critical care and women's healthcare, while creating opportunities to expand its product offerings in international markets. A key strategic rationale for the acquisition is the…
DPIIT eyes Budget FY28 push to localise 100 import-heavy items - from pharma to machinery
The support could take the form of a combination of fiscal and non-fiscal measures such as capital-linked incentives, temporary tariff protections, targeted R&D funding, help in testing and certification and enhanced supply-chain credit, the source…
Avalyn Pharma (NASDAQ:AVLN) Shares Gap Up - Here's What Happened
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares gapped up prior to trading on Monday. The stock had previously closed at $26.67, but opened at $30.74. Avalyn Pharma shares last traded at $29.74, with a volume of 8,149 shares traded.
Nifty slips below 25,000 as IT, power stocks drag; banks, pharma hold firm
Updated - November 09, 2026 at 09:51 AM. Markets opened on a cautious note Monday morning, with the benchmark Nifty 50 declining 30.40 points, or 0.12 per cent, to trade at 24,956 as of 9.29 am, after closing at 24,986.40 on Sunday's Muhurat…
FY2026 EPS Estimate for Urogen Pharma Lifted by Analyst
3 Bullish Biotech Stocks With Explosive Growth Trends Urogen Pharma (NASDAQ:URGN - Free Report) - Equities researchers at HC Wainwright boosted their FY2026 earnings per share estimates for Urogen Pharma in a research report issued on Thursday…
Spyglass Pharma (NASDAQ:SGP) Sets New 1-Year High - Still a Buy?
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) reached a new 52-week high during trading on Monday. The company traded as high as $39.92 and last traded at $37.6840, with a volume of 18,000 shares changing hands. The stock had previously…
25,458 Royalty Pharma PLC $RPRX Shares Sold by Formidable Asset Management LLC
Formidable Asset Management LLC reduced its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 79.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional…
Royalty Pharma PLC $RPRX Shares Sold by Bryn Mawr Trust Advisors LLC
Bryn Mawr Trust Advisors LLC lessened its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 11.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 272,283 shares of the…
16,584 Shares of Ascendis Pharma A/S $ASND Acquired by Kornitzer Capital Management Inc. KS
Kornitzer Capital Management Inc. KS acquired a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm…
242,703 BridgeBio Pharma, Inc. $BBIO Shares Acquired by Pictet Asset Management Holding SA
Pictet Asset Management Holding SA increased its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 16.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
143,912 Shares in Royalty Pharma PLC $RPRX Bought by Hohimer Wealth Management LLC
Hohimer Wealth Management LLC acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 143,912 shares of the…
17,781 BridgeBio Pharma, Inc. $BBIO Shares Sold by University of Texas Texas AM Investment Management Co.
University of Texas Texas AM Investment Management Co. trimmed its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 54.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC.
Evesham mother told epilepsy drug would not harm unborn baby
Rosemary Nayler says she was repeatedly told that taking the epilepsy drug sodium valproate while pregnant would not affect her unborn child. But it is thought thousands of children in the UK have been left with disabilities caused by the…
Receive a Daily briefing on Pharma Industry News
Get Started